ITGI Medical Ltd. (TASE:ITGI), which develops, manufactures and markets a line of stents covered with living tissue, today reported that it has signed distribution deals for its AneuGraft stents in Asia and a first ever deal in Australia.
ITGI has signed three separate deals with companies who will act as exclusive distributors in their regions. The companies are all leading distributors of advanced medical technology solutions for major medical device manufacturers include many products in the field of cardiology intervention. The deals are for three years and follow a recent distribution agreement in India.
The agreements were signed at the Transcatheter Cardiovascular Therapeutics (TCT) exhibition in Washington DC where the AneuGraft stents have captured the attention of leading figures in the field of cardiology.
In afternoon trading ITGI Medical's share price was down 0.79% to NIS 3.95.
Published by Globes, Israel business news - www.globes-online.com - on October 6, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010